Warning: Invalid argument supplied for foreach() in /home/globaldi/public_html/modules/mod_banners/tmpl/default.php on line 9
 

Akorn jumps on FDA approval. Cambridge Heart leaps on 510 k clearence. Viking ... - BioMedReports (subscription) PDF Print
BioMedReports (subscription)The Company's Phase 3 clinical program of Zerenex as a treatment for hyperphosphatemia in patients with end-stage renal disease who are on dialysis is

... read more

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.